September 2018—The advantages of moving from stool culture to a molecular platform are many: faster time to results, more accurate pathogen identification, a savings of space and staff time. For Jose Alexander, MD, D(ABMM), SM, MB(ASCP), and colleagues at Florida Hospital Orlando, another plus is being able to adhere to the Infectious Diseases Society of America guideline suggestion that labs use a diagnostic approach that can distinguish O157 from non-O157 E. coli and Shiga toxin 1 from Shiga toxin 2 E. coli.Read More »
August 2018—Testing turnaround times can affect whether non-small cell lung cancer patients receive an EGFR or ALK tyrosine kinase inhibitor when indicated. At disease progression on an EGFR TKI, integrating circulating tumor DNA and tissue-based testing may lessen some of the limitations of each form of testing.Read More »
Webinar presenters Matthew Bell, Mike Broyles, PharmD, and Eric Gluck, MD, discuss current laboratory/clinical practice, how to use procalcitonin in sepsis and LRTI to determine when to start and stop antibiotic therapy, the importance of procalcitonin assay precision and sensitivity to support clinical decisions, and the impact of procalcitonin testing on antibiotic stewardship. This on-demand webinar originally broadcast on August 21, 2018.
Webinar presenters Margie A. Morgan, PhD, D(ABMM), and Gregory J. Berry, PhD, D(ABMM), discuss the impacts of this past year’s flu season. This webinar will empower you to anticipate the impact of another significant flu season, assess your health care system testing needs; and choose the appropriate tests/algorithm for your lab. This on-demand webinar originally broadcast on August 15, 2018.
Webinar presenters Tabetha Sundin, PhD, HCLD(ABB), MB(ASCP)CM and Leigha Senter-Jamieson, MS, discuss the rationale for BRCA mutation testing in breast cancer, key highlights of the BRCA testing and interpretation process, and reconsidering multi-disciplinary team roles and responsibilities to streamline the testing experience. This on-demand webinar was originally broadcast on March 29, 2018.
Webinar presenter Yaolin Zhou, MD, discusses a new model for quality improvement which can be applied to laboratory testing, including molecular pathology testing. This on-demand webinar originally broadcast on June 14, 2018.
Webinar presenter Jay M. Lieberman, MD, discusses the epidemiology, clinical manifestations, and treatment of HSV infections, as well as prevention strategies, and the appropriate use and interpretation of diagnostic tests. This on-demand webinar originally broadcast on March 16, 2018.
Practical considerations and real-world examples: CAP/IASLC/AMP molecular testing guideline updates for NSCLC
Webinar presenter Michelle Shiller, DO, MSPT, discusses key updates to the CAP/IASLC/AMP guideline recommendations for molecular testing in patients with NSCLC and the impact of the CAP/IASLC/AMP guideline recommendations on clinical practice illustrated through testing case scenarios. This on-demand webinar originally broadcast on May 9, 2018.Read More »
Webinar presenters Daniel D. Rhoads, MD and Jose (Alex) Alexander, MD, D(ABMM), SM, MB(ASCP) discuss molecular GI testing, the application of new guidelines, the impact of molecular GI testing, and tips for implementation and justification. This on-demand webinar was originally broadcast on April 25, 2018.
On demand webinar—Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing
This webinar will empower you to learn the how and why of NGS testing for NSCLC therapy selection, how to practice precision oncology based on fast-changing guidelines and to ensure even challenging samples get tested to achieve best outcomes for as many NSCLC patients as possible, and Cancer Genetics Inc. (CGI) testing model, case studies and lessons learned. Originally broadcast: March 28, 2018